SANUWAVE, Inc. Wins Patent Challenge

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE’s U.S. Patent No. 6,080,119 following a third party’s ex parte reexamination request. This innovative device and method patent describes the Company’s invention of effective catalyst concentrations to produce optimal medical shock waves.